The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Transaction with Affiliate Company

29 Oct 2020 08:03

RNS Number : 6003D
Samsung Electronics Co. Ld
29 October 2020
 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on October 29, 2020 announced that its Board of Directors has authorized the following related-party transaction with an affiliated company.

 

Trademark License Agreement

- Grant trademark license to Samsung Biologics

Major Transaction Terms

Transaction Item

License fee for use of trademark

Transaction Date

November 30, 2018

Transaction Period

February 1, 2018-January 31, 2021

Transaction Value

KRW 9,779 million

(total transaction value: KRW 9,779 million)

Contract Type

Negotiated contract

Other information

* On a cumulative basis, the license fee was below KRW 5 billion at the end of

2019, but exceeded KRW 5 billion after adding the fee for 2020. Accordingly,

the payment shall be made upon the approval of the Board of Directors.

 

* The transaction date is the date when the trade license agreement with

Samsung Biologics was made.

 

* The transaction value is an estimate of cumulative license fee during the

transaction period (3 years) and may change according to Samsung Biologics

revenue.

 

* The license fee is set at 0.5% of Samsung Biologics' revenue (excluding

revenue or purchases not related to the use of trademark) and shall be paid

every year during the transaction period.

Other Information:

ž Number of Independent Directors Present at the BOD Meeting: 6/6

ž Attendance of Audit Committee: Y

 

This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose financial and

real estate transactions in the event the value of such a transaction is greater or equal to KRW 5 billion and the counterparty is

a financial affiliate of the party required to make the disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEFSAUESSESS

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.